Temperature sensitive hydrogel for preoperative treatment of renal carcinoma.

Surgical resection has been suggested as an effective and first-line treatment of renal cell carcinoma (RCC). However, operation is quite difficult for the patients with stage of middle-late or hypervascularized tumors. Transarterial chemoembolization (TACE) plays an important role in decreasing the size of tumors before surgery. In this work, we prepared an injectable drug-delivery system of doxorubicin-loaded temperature sensitive hydrogel for transarterial chemoembolization in RCC. The sol-gel transition behavior and rheologic analysis showed that the doxorubicin-loaded temperature sensitive hydrogel had good temperature sensitivity. Then, The X-ray experiment of hydrogel showed excellent visibility under the digital subtraction angiography and computed tomography scans in vitro and in vivo. Moreover, the studies of embolization in beagle's right kidney showed good properties in embolizing of renal arteries. In TACE therapy studies of rabbit VX2 renal tumors, angiography, computed tomography and histopathological analysis verified that TACE therapy of doxorubicin-loaded temperature sensitive hydrogel had excellent embolic efficiency as a result of repressing the tumor growth. This hydrogel could provide valuable option in the treatment of renal cell carcinoma before surgery.

Materials science & engineering. C, Materials for biological applications. 2020 Mar 02 [Epub]

Yang He, Tianwen Yuan, Xing Wang, Ming Shen, Li Ding, Lili Huang, Saibo Wang, Peng Kong, Xing Zhou, Yourong Duan, Jun Cao

Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, People's Republic of China., State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's republic of China., State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's republic of China. Electronic address: ., Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, People's Republic of China. Electronic address: .